What is Assembly Biosciences, Inc. (ASMB)?
Assembly Biosciences, Inc. is a biotechnology company engaged in the development of novel therapies targeting viral infections and liver diseases. The company focuses on discovering and advancing treatments for chronic hepatitis B virus infection and other related conditions. Assembly Biosciences employs a research-driven approach to develop small molecule therapeutics aimed at addressing unmet medical needs. Its pipeline includes candidates designed to inhibit viral replication and modulate immune responses. The company operates within the biopharmaceutical industry, collaborating with research institutions and leveraging scientific innovation to develop potential therapies.
Assembly Biosciences, Inc. Stock Price Today: Live Overview
The price today is shaped by intraday market activity, with Assembly Biosciences, Inc. trading at $28.7000. The price has fluctuated from $27.65 to $29.95, reflecting a daily change percentage of +1.1364%.
FAQ: Assembly Biosciences, Inc. (ASMB)
What is the current price of ASMB stock?
The current price is $28.7000.
Does ASMB pay dividends?
Assembly Biosciences, Inc. does not pay dividends.
Does ASMB have a formal corporate presence or regional headquarters in the UAE?
Assembly Biosciences, Inc. operates in the UAE through partners without an official office or subsidiary.
What is ASMB best known for?
It is most famous for developing therapies for viral infections and liver diseases.
What assets are typically shown together with ASMB?
Commonly shown alongside ASMB: Radiant Logistics Inc, Ramsay Health Care Limited, Brambles Limited
Latest shares articles



